Works citing this work

4 works

Work: Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

1. Metal nanoparticles as a promising therapeutic approach for prostate cancer diagnosis and therapy: a comprehensive review

   Mohamed J. Saadh, Wajida Ataallah Khidr, Karar H. Alfarttoosi +9

   Review articleNanoparticle-Based Drug DeliveryMedical Oncology20250 citations

   ABIABI:AkademIndex/openalex/2025.review-article.000031

2. Regulatory T Cells in Colon Cancer: Implications for Pathogenesis, Prognosis and Emerging Therapeutic Strategies

   Faris Anad Muhammad, Abdulkareem Shareef, S. Renuka Jyothi +10

   Review articleT-cell and B-cell ImmunologyImmunological Investigations20250 citations

   ABIABI:AkademIndex/openalex/2025.review-article.000109

3. Immunological functions of Th17 Cells in colon cancer: From pathogenic mechanisms to emerging treatments

   Qamar Abuhassan, Ali M Atoom, M.M. Rekha +5

   ArticlePsoriasis: Treatment and PathogenesisHuman Immunology20260 citations

   ABIABI:AkademIndex/openalex/2026.article.004934

4. Hypoxia‐Inducible Factors as Guardians of Cancer Stem Cell Fate: Implications for Novel Therapies

   Qamar Abuhassan, Hamzeh J. Al‐Ameer, Hani Moslem Ahmed +4

   ArticleCancer, Hypoxia, and MetabolismIUBMB Life20260 citations

   ABIABI:AkademIndex/openalex/2026.article.013100